Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01723488 · ClinicalTrials.gov registry record · Early Phase 1
A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808
A Early Phase 1 study, sponsored by Avid Radiopharmaceuticals.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 12
- Enrollment target
NCT01723488 is a Early Phase 1 study that was terminated before completion, run by Avid Radiopharmaceuticals. The registered enrollment target is 12 participants.
The verdict
NCT01723488, a Early Phase 1 study, was terminated before completion, sponsored by Avid Radiopharmaceuticals.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
\[F-18\]T808 is being developed as a diagnostic radiopharmaceutical for PET imaging of the human brain.
Interventions
- RADIATION [F18] T808
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2012-07 |
| Est. Completion | 2013-03 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01723488
The ClinicalTrials.gov registry entry for NCT01723488 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Avid Radiopharmaceuticals, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [F18] T808 is the first listed.
NCT01723488 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01723488 about?
NCT01723488 is a clinical study titled "A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808". \[F-18\]T808 is being developed as a diagnostic radiopharmaceutical for PET imaging of the human brain.
What is the current status of trial NCT01723488?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 12 participants. The study started on 2012-07. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01723488?
The interventions under investigation include: [F18] T808 (RADIATION).
Who is sponsoring clinical trial NCT01723488?
This trial is sponsored by Avid Radiopharmaceuticals, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.